与新发PTEN突变相关的多灶性脱髓鞘运动神经病和错构瘤综合征
本文报道一名儿童期起病的非对称性进行性多灶性运动神经病患者,伴巨头畸形、孤独症谱系障碍和皮肤错构瘤,符合PTEN相关错构瘤肿瘤综合征临床标准。全外显子测序检出新型新发杂合PTEN变异c.269T>C,p.(Phe90Ser),父母均无该变异;患者成纤维细胞显示PTEN对第二底物磷脂酰肌醇3,4,5-三磷酸的催化活性缺陷。作者提出PTEN相关多灶性脱髓鞘运动神经病伴皮肤错构瘤综合征为新表型。
要点
- 儿童期起病的非对称性进行性多灶性运动神经病可伴PTEN相关错构瘤肿瘤综合征临床特征。
- 检出新型新发杂合PTEN变异c.269T>C,p.(Phe90Ser),父母均无该变异。
- 患者成纤维细胞显示PTEN对磷脂酰肌醇3,4,5-三磷酸的催化活性缺陷。
核心结论
- 作者描述了一种新表型:PTEN相关多灶性脱髓鞘运动神经病伴皮肤错构瘤综合征。
- 作者认为相似机制可能潜在涉及其他累及磷脂酰肌醇通路的腓骨肌萎缩症(Charcot-Marie-Tooth病)类型。
研究设计与样本
- 对患者基因组DNA行全外显子测序并经Sanger测序验证。
- 在患者成纤维细胞中行免疫印迹、体外酶学测定和无标记鸟枪法蛋白质组学分析。
主要发现
- 患者主要临床表现为儿童期起病的非对称性进行性多灶性运动神经病。
- 患者还表现为巨头畸形、孤独症谱系障碍和皮肤错构瘤,被视为PTEN相关错构瘤肿瘤综合征的临床标准。
- 广泛肿瘤筛查未检出任何恶性肿瘤。
- 检出新型新发杂合PTEN变异c.269T>C,p.(Phe90Ser),父母双方均无该变异。
- 成纤维细胞显示PTEN对第二底物磷脂酰肌醇3,4,5-三磷酸的催化活性缺陷。
关键数值与推荐
- 该变异致病性由多个参与肿瘤发生的PTEN相关蛋白表达改变所支持。
- PTEN缺陷小鼠中已报道导致周围神经病的局灶性过度髓鞘化,支持本研究发现。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe a patient with a multifocal demyelinating motor neuropathy with onset in childhood and a mutation in phosphatase and tensin homolog (PTEN), a tumor suppressor gene associated with inherited tumor susceptibility conditions, macrocephaly, autism, ataxia, tremor, and epilepsy. Functional implications of this protein have been investigated in Parkinson and Alzheimer diseases. METHODS: We performed whole-exome sequencing in the patient's genomic DNA validated by Sanger sequencing. Immunoblotting, in vitro enzymatic assay, and label-free shotgun proteomic profiling were performed in the patient's fibroblasts. RESULTS: The predominant clinical presentation of the patient was a childhood onset, asymmetric progressive multifocal motor neuropathy. In addition, he presented with macrocephaly, autism spectrum disorder, and skin hamartomas, considered as clinical criteria for PTEN-related hamartoma tumor syndrome. Extensive tumor screening did not detect any malignancies. We detected a novel de novo heterozygous c.269T>C, p.(Phe90Ser) PTEN variant, which was absent in both parents. The pathogenicity of the variant is supported by altered expression of several PTEN-associated proteins involved in tumorigenesis. Moreover, fibroblasts showed a defect in catalytic activity of PTEN against the secondary substrate, phosphatidylinositol 3,4-trisphosphate. In support of our findings, focal hypermyelination leading to peripheral neuropathy has been reported in PTEN-deficient mice. CONCLUSION: We describe a novel phenotype, PTEN-associated multifocal demyelinating motor neuropathy with a skin hamartoma syndrome. A similar mechanism may potentially underlie other forms of Charcot-Marie-Tooth disease with involvement of the phosphatidylinositol pathway.
引用
- Bansagi B, Phan V, Baker MR, et al. Multifocal demyelinating motor neuropathy and hamartoma syndrome associated with a de novo PTEN mutation. Neurology. 2018. PMID: 29720545. doi:10.1212/WNL.0000000000005566
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。